14.2 Citric Acid Cycle, Mitochondrial Electron Transport, Oxidative Phosphorylation, and $\beta$-Oxidation
Key Takeaways
The Pyruvate Dehydrogenase Complex (PDC) catalyzes the irreversible oxidative decarboxylation of pyruvate to acetyl-CoA using three enzymes () and five cofactors (TPP, lipoamide, CoA-SH, FAD, ); it is inactivated by PDC kinase phosphorylation and inhibited by arsenite binding to lipoamide dithiols.
One complete turn of the Citric Acid Cycle (TCA cycle) oxidizes one acetyl-CoA, producing , , (via substrate-level phosphorylation by succinyl-CoA synthetase), and ; succinate dehydrogenase is an integral inner membrane enzyme serving simultaneously as Complex II of the ETC.
The mitochondrial Electron Transport Chain transfers electrons from through Complexes I, III, and IV, pumping into the intermembrane space; electrons from enter at Complex II and traverse Complexes III and IV, pumping .
The chemiosmotic hypothesis states that the proton-motive force () drives ATP synthesis via the ATP synthase, operating via Paul Boyer's rotational binding-change mechanism with P/O ratios of for and for .
Respiratory chain inhibitors (cyanide, CO, azide blocking Complex IV; antimycin A blocking Complex III; rotenone blocking Complex I) halt both electron transport and ATP synthesis, whereas uncouplers (2,4-DNP, UCP-1/thermogenin) dissipate the proton gradient, collapsing ATP synthesis while stimulating respiration and generating heat.
14.2 Citric Acid Cycle, Mitochondrial Electron Transport, Oxidative Phosphorylation, and -Oxidation
Quick Answer: The mitochondrial matrix and inner mitochondrial membrane host the terminal oxidative machinery of the cell. The pyruvate dehydrogenase complex (PDC) oxidatively decarboxylates pyruvate into acetyl-CoA, coupling glycolysis to the citric acid cycle using five distinct coenzymes (TPP, lipoic acid, CoA, FAD, ). Each acetyl-CoA entering the citric acid cycle yields , , (substrate-level phosphorylation), and . Electrons from and traverse the electron transport chain (ETC) to reduce to , pumping protons across the inner mitochondrial membrane ( per , per ). The resulting proton-motive force () drives rotational ATP synthesis by the ATP synthase, yielding per and per . Complete oxidation of glucose yields depending on whether the glycerol-3-phosphate or malate-aspartate shuttle is used. Fatty acids are activated to acyl-CoA, translocated via the carnitine shuttle (inhibited by malonyl-CoA), and degraded through the 4-step -oxidation spiral, yielding from palmitate (). Under carbohydrate deprivation, excess acetyl-CoA is shunted to ketone bodies, which fuel the heart and brain but cannot be consumed by the liver.
The Pyruvate Dehydrogenase Complex (PDC)
Pyruvate produced by glycolysis in the cytosol enters the mitochondrial matrix via the mitochondrial pyruvate carrier (MPC, a proton-symporter). In the matrix, pyruvate undergoes irreversible oxidative decarboxylation to acetyl-CoA catalyzed by the Pyruvate Dehydrogenase Complex (PDC):
This reaction represents the critical metabolic bridge connecting carbohydrate catabolism to the citric acid cycle and lipid biosynthesis. It is strictly irreversible in animals; acetyl-CoA cannot be converted back into pyruvate or glucose.
Subunit Composition and the Five Coenzymes
The PDC is a massive non-covalent multienzyme assembly () comprising multiple copies of three catalytic enzymes and five specialized coenzymes:
| Subunit | Enzyme Name | Prosthetic Group / Coenzyme | Primary Function in Mechanism |
|---|---|---|---|
| Pyruvate Dehydrogenase | Thiamine Pyrophosphate (TPP) | Decarboxylates pyruvate, forming a hydroxyethyl-TPP carbanion intermediate | |
| Dihydrolipoyl Transacetylase | Lipoamide (prosthetic) and Coenzyme A (substrate) | Oxidizes hydroxyethyl group to acetyl group; transfers acetyl to CoA, forming Acetyl-CoA and dihydrolipoamide | |
| Dihydrolipoyl Dehydrogenase | FAD (prosthetic) and (substrate) | Re-oxidizes reduced dihydrolipoamide back to lipoamide disulfide; transfers electrons to via |
PDC Five-Step Catalytic Cycle:
1. E1: Pyruvate + TPP --> Hydroxyethyl-TPP + CO2
2. E1/E2: Hydroxyethyl-TPP + Lipoamide(S-S) --> Acetyllipoamide(S-Ac, SH) + TPP
3. E2: Acetyllipoamide + CoA-SH --> Acetyl-CoA + Dihydrolipoamide(SH, SH)
4. E3: Dihydrolipoamide(SH, SH) + E3-[FAD] --> Lipoamide(S-S) + E3-[FADH2]
5. E3: E3-[FADH2] + NAD+ --> E3-[FAD] + NADH + H+
- The Swinging Lipoamide Arm: The lipoyl group of is covalently bound via an amide linkage to the -amino group of a specific lysine residue, creating a flexible long hydrocarbon "swinging arm". This arm visits the active site of to receive the acetyl group, transfers it to CoA in the core, and swings to to be re-oxidized by FAD.
- The Chemical Paradox of : Standard reduction potentials dictate that electrons normally flow from lower to higher . Free has , whereas has . In , the local protein environment alters the reduction potential of the enzyme-bound FAD to approximately , allowing electron transfer from to to proceed favorably!
Regulation and Clinical Toxicology of PDC
- Allosteric Feedback: PDC is allosterically inhibited by its direct products: acetyl-CoA (inhibits ) and (inhibits ).
- Covalent Phosphorylation (PDC Kinase vs. PDC Phosphatase):
- PDC Kinase: Phosphorylates three specific Ser residues on , completely inactivating the complex. PDC kinase is activated by high energy indicators (high , , and ) and inhibited by pyruvate and ADP.
- PDC Phosphatase: Hydrolyzes the serine phosphate groups, reactivating PDC. It is activated by (signaling muscle contraction) and insulin (in adipocytes).
- Arsenite and Heavy Metal Poisoning: Arsenite () and mercury compounds bind with high affinity to the vicinal sulfhydryl groups (dithiols) of reduced dihydrolipoamide, forming a stable cyclic thioarsenite chelate ring. This permanently arrests turnover, halting both the PDC and the -ketoglutarate dehydrogenase complex, starving the brain of aerobic ATP and causing central nervous system pathology.
The Citric Acid Cycle (Krebs Cycle / TCA Cycle)
The citric acid cycle is an amphibolic pathway that completely oxidizes the two-carbon acetyl unit of acetyl-CoA into two molecules of .
The Eight Enzymatic Reactions
| Step | Enzyme | Reaction Type | Reactants Products | (kJ/mol) | Mechanistic & Regulatory Notes |
|---|---|---|---|---|---|
| 1 | Citrate Synthase | Aldol condensation / Thioester hydrolysis | Committed entry step; inhibited by ATP, NADH, succinyl-CoA, citrate | ||
| 2 | Aconitase | Dehydration / Rehydration | iron-sulfur cluster; inhibited by fluorocitrate | ||
| 3 | Isocitrate Dehydrogenase | Oxidative decarboxylation | Rate-limiting step; Mn; activated by ADP/Ca, inhibited by ATP/NADH | ||
| 4 | -Ketoglutarate Dehydrogenase | Oxidative decarboxylation | Multienzyme complex identical to PDC; inhibited by Succinyl-CoA, NADH | ||
| 5 | Succinyl-CoA Synthetase | Substrate-level phosphorylation | Phospho-histidine intermediate; only substrate-level phosphorylation in TCA | ||
| 6 | Succinate Dehydrogenase | Dehydrogenation | Complex II of ETC; covalent FAD, 3 Fe-S centers; inhibited by malonate | ||
| 7 | Fumarase | Hydration | Stereospecific trans-addition of water across double bond | ||
| 8 | Malate Dehydrogenase | Oxidation | Endothermic; pulled forward by low from citrate synthase |
Net Stoichiometry per Acetyl-CoA
Notice that the two carbons released as in any single turn of the cycle are not the two carbons that just entered from acetyl-CoA; they originate from the oxaloacetate backbone (traceable via -labeling experiments).
Anaplerotic Reactions
Because the citric acid cycle is amphibolic, intermediates are constantly siphoned off for anabolic biosyntheses (e.g., -ketoglutarate glutamate; oxaloacetate aspartate; succinyl-CoA porphyrins and heme; citrate fatty acids). To maintain catalytic flux, anaplerotic (filling-up) reactions replenish cycle intermediates:
- Pyruvate Carboxylase: The premier anaplerotic reaction in liver and kidney:
- Glutamate Dehydrogenase: Converts glutamate into -ketoglutarate.
- Propionyl-CoA Carboxylase: Converts propionyl-CoA (from odd-chain fatty acids) into succinyl-CoA.
The Mitochondrial Electron Transport Chain (ETC)
The respiratory chain consists of four large multiprotein complexes embedded in the inner mitochondrial membrane (IMM) and two mobile electron carriers: coenzyme Q (ubiquinone) and cytochrome c.
Electrons flow spontaneously along a thermodynamic gradient from negative standard reduction potentials () toward oxygen, the terminal electron acceptor ():
Mitochondrial Electron Transport Chain Complexes & Proton Translocation:
Intermembrane Space (IMS) [4 H+] [4 H+] [2 H+]
------------------------------^-----------------------^---------------^------
Inner Membrane (IMM) | | |
Complex I Q-Cycle Complex III Complex IV
(NADH:Q OR) --> [Q] --> (Cyt bc1) --> [Cyt c] --> (Cyt c Oxidase)
^ ^ |
| | v
Matrix NADH + H+ Complex II 1/2 O2 + 2 H+
(Succinate:Q) |
^ v
Succinate H2O
The Four Respiratory Complexes
-
Complex I (NADH:Ubiquinone Oxidoreductase):
- Massive L-shaped complex (45 subunits, ) with one arm in the membrane and one extending into the matrix.
- Accepts two electrons from via flavin mononucleotide (FMN), which then pass through a chain of iron-sulfur centers ( and ) to reduce ubiquinone (Q) to ubiquinol ().
- Electron transfer drives conformational changes in long horizontal -helices, pumping per NADH across the IMM into the intermembrane space (IMS).
-
Complex II (Succinate Dehydrogenase / Succinate:Ubiquinone Oxidoreductase):
- The only membrane-bound enzyme of the TCA cycle; contains four subunits, covalently bound FAD, three Fe-S centers, and a cytochrome .
- Transfers electrons from succinate to FAD, through the Fe-S centers, to Q, forming .
- Because between succinate () and ubiquinone () is very small (), no protons are pumped across the membrane at Complex II ().
-
Coenzyme Q (Ubiquinone / CoQ):
- A hydrophobic benzoquinone attached to a long isoprenoid tail (10 units in humans: ), allowing it to diffuse rapidly within the lipid core of the IMM.
- Acts as a mobile two-electron, two-proton carrier that collects reducing equivalents from Complex I, Complex II, electron-transferring flavoprotein (ETF:ubiquinone oxidoreductase from fatty acid -oxidation), and glycerol-3-phosphate dehydrogenase.
-
Complex III (Cytochrome Complex / Ubiquinol:Cytochrome c Oxidoreductase):
- A homodimer containing cytochrome (hemes and ), the Rieske protein, and cytochrome .
- Catalyzes the Q-Cycle: Because is an obligatory two-electron carrier and cytochrome c is an obligatory single-electron carrier (), the Q-cycle bifurcates electron flow. For every pair of electrons transferred to two molecules of cytochrome c, are pumped into the IMS and two protons are taken up from the matrix.
-
Cytochrome c:
- A small, water-soluble peripheral hemeprotein () located in the intermembrane space that ferries single electrons from Complex III to Complex IV.
-
Complex IV (Cytochrome c Oxidase):
- Homodimer (13 subunits per monomer) containing two heme groups (hemes and ) and two copper centers (binuclear and mononuclear ).
- Heme and form a binuclear center that coordinates and activates molecular oxygen ():
- For every pair of electrons (1/2 ), are pumped into the IMS, and two chemical protons from the matrix are consumed into .
Total Proton Translocation Stoichiometry
- Per mole of : pumped into IMS.
- Per mole of : pumped into IMS.
Chemiosmotic Hypothesis and the ATP Synthase Mechanism
Proposed by Peter Mitchell in 1961 (Nobel Prize, 1978), the chemiosmotic hypothesis established that the free energy of electron transport is conserved by pumping protons out of the matrix, establishing an electrochemical proton gradient termed the proton-motive force ():
Where:
- = electrical membrane potential across the IMM (, matrix negative).
- = chemical pH gradient (matrix is alkaline by ).
- At physiological temperature ( / ), .
- Total Proton-Motive Force: (directed inward toward the matrix).
ATP Synthase ( Complex) and Boyer's Rotational Catalysis
ATP synthase () consists of two functional sectors:
- Sector (Hydrophobic, Membrane-Spanning): Comprises a static subunit (containing two non-connecting proton half-channels) and a rotating ring of hydrophobic subunits ( subunits in mammalian mitochondria). Each subunit bears a crucial carboxyl group (Asp-61 in E. coli or Glu-58 in animals) that binds a proton from the IMS half-channel, rotates through the lipid bilayer, and releases the proton into the matrix half-channel.
- Sector (Hydrophilic, Matrix-Facing Catalytic Head): Comprises an hexamer held stationary by a peripheral stator stalk (). The central asymmetric shaft is firmly fixed to the rotating -ring.
Paul Boyer's Binding-Change Mechanism for the Three Beta Subunits:
[Open (O) State] -----> Binds ADP + Pi loosely
|
v
[Loose (L) State] -----> Traps substrates in active site
|
v
[Tight (T) State] -----> Conformation forces condensation to ATP
|
v
[Open (O) State] -----> Releases newly formed ATP into matrix
- Energy Requirement of ATP Synthesis: Paul Boyer's binding-change studies (begun in the 1970s; Nobel Prize 1997) showed that on the enzyme surface of the Tight () subunit, the equilibrium constant for is near unity (). The enzyme binds ATP with such extraordinary affinity () that ATP forms spontaneously. The proton-motive force is NOT required to synthesize the phosphoanhydride bond; it is required to rotate the stalk and force open the subunit to release the bound ATP!
- Rotation Stoichiometry: One full rotation of the -ring rotates the stalk through all three subunits, releasing molecules. In mammalian mitochondria with an -ring, are transported per rotation, giving per ATP synthesized.
- Phosphate Import Cost: Import of into the matrix occurs via the electroneutral phosphate translocase ( symporter), consuming per ATP. Export of in exchange for via the electrogenic adenine nucleotide translocase (ANT) consumes one unit of membrane potential ( equivalent).
- Total Proton Cost per ATP Exported: about for synthesis plus about for moving , ADP, and ATP across the membrane, which standard P/O accounting rounds to .
Modern P/O Ratios and Net ATP Yield of Glucose Oxidation
Mitochondrial Shuttles for Cytosolic NADH
Because the inner mitochondrial membrane is impermeable to and , cytosolic from glycolysis enters mitochondria via two shuttle systems:
- Malate-Aspartate Shuttle (Liver, Kidney, Heart): Cytosolic reduces OAA to malate, which enters the matrix and is re-oxidized by mitochondrial malate dehydrogenase to generate matrix . Yields per cytosolic NADH (Net: per glucose).
- Glycerol-3-Phosphate Shuttle (Skeletal Muscle, Brain): Cytosolic reduces DHAP to glycerol-3-phosphate. Mitochondrial glycerol-3-phosphate dehydrogenase on the outer surface of the IMM transfers electrons to FAD, producing , which enters the ETC at Coenzyme Q. Yields per cytosolic NADH (Net: per glucose).
| Pathway Stage | Direct Product | Phosphorylation Mechanism | Net ATP (Glycerol-3-P Shuttle) | Net ATP (Malate-Asp Shuttle) |
|---|---|---|---|---|
| Glycolysis | Substrate-level | |||
| Glycolysis | Oxidative via Shuttle | |||
| Pyruvate Dehydrogenase | Oxidative (Matrix) | |||
| Citric Acid Cycle | Substrate-level | |||
| Citric Acid Cycle | Oxidative (Matrix) | |||
| Citric Acid Cycle | Oxidative (Matrix) | |||
| Total Net Yield per Glucose | — | — |
Bioenergetic Pharmacology: Inhibitors and Uncouplers
| Agent | Target / Mechanism | Effect on Electron Transport ( consumption) | Effect on ATP Synthesis | Effect on Proton Gradient () |
|---|---|---|---|---|
| Rotenone / Amytal | Blocks Fe-S centers of Complex I | Inhibited (with NADH-linked substrates) | Inhibited | Collapses |
| Malonate | Competitive inhibitor of Complex II (Succinate DH) | Inhibited (with succinate substrate) | Inhibited | Collapses |
| Antimycin A | Blocks site of Complex III (Cytochrome ) | Inhibited | Inhibited | Collapses |
| Cyanide (), Carbon Monoxide (CO), Azide () | Binds tightly to heme and of Complex IV | Completely Blocked | Completely Blocked | Collapses completely |
| Oligomycin | Binds -ring / stalk of sector, blocking proton channel | Inhibited (due to high backpressure of ) | Inhibited | Markedly Increases |
| 2,4-Dinitrophenol (DNP), FCCP | Lipophilic protonophores (Uncouplers); shuttles across IMM | Maximally Accelerated | Completely Blocked | Abolished (Energy dissipated as heat) |
| Thermogenin (UCP-1) | Physiological uncoupling protein in brown adipose tissue | Accelerated | Decreased | Dissipated into non-shivering thermogenesis |
| Atractyloside / Bongkrekic Acid | Inhibits Adenine Nucleotide Translocase (ANT) | Inhibited | Inhibited | Increases |
PRC Board Exam Distinguishing Criterion: To differentiate an ATP synthase inhibitor (oligomycin) from an ETC complex inhibitor (cyanide): adding an uncoupler like DNP to an oligomycin-inhibited system restores rapid oxygen consumption (because the ETC machinery is intact; it was merely halted by excessive proton back-pressure). Adding DNP to a cyanide-inhibited system has zero effect because Complex IV is physically poisoned.
Lipid Catabolism: Activation, Carnitine Shuttle, and -Oxidation
Triacylglycerols stored in adipocytes are mobilized by hormone-sensitive lipase (HSL) and adipose triglyceride lipase (ATGL) in response to glucagon and epinephrine (via cAMP/PKA phosphorylation), releasing free fatty acids into the bloodstream bound to serum albumin.
1. Fatty Acid Activation
In the cytosol, fatty acids are activated to fatty acyl-CoA by fatty acyl-CoA synthetase (thiokinase) located on the outer mitochondrial membrane:
Notice that activation consumes two high-energy phosphate bonds (), equivalent to spending .
2. The Carnitine Shuttle (Rate-Limiting Translocation Step)
While the outer mitochondrial membrane is permeable to acyl-CoA, the inner mitochondrial membrane is strictly impermeable to CoA esters. Long-chain acyl-CoA () must use the carnitine shuttle:
The Carnitine Shuttle System:
Outer Mitochondrial Membrane (OMM):
Fatty Acyl-CoA + Carnitine ====(CPT-I)====> Fatty Acylcarnitine + CoA-SH
|
Intermembrane Space (IMS) v
Inner Mitochondrial Membrane (IMM): [Carnitine-Acylcarnitine Translocase]
|
Mitochondrial Matrix: v
Fatty Acylcarnitine + CoA-SH ====(CPT-II)====> Fatty Acyl-CoA + Carnitine
- Carnitine Palmitoyltransferase I (CPT-I / CAT-I): Resides on the outer mitochondrial membrane; catalyzes the transfer of the fatty acyl group from CoA to the hydroxyl group of carnitine, forming fatty acylcarnitine.
- Allosteric Regulation by Malonyl-CoA: CPT-I is potently inhibited by malonyl-CoA, the first committed intermediate in fatty acid biosynthesis. When the liver is actively synthesizing fatty acids from carbohydrates, malonyl-CoA levels rise, shutting down CPT-I and preventing newly synthesized fatty acids from entering mitochondria to be degraded (preventing a futile cycle).
- Carnitine-Acylcarnitine Translocase: An antiporter in the IMM that moves acylcarnitine into the matrix while exporting free carnitine back to the intermembrane space.
- Carnitine Palmitoyltransferase II (CPT-II): Located on the inner surface of the IMM; transfers the acyl group back onto matrix CoA, regenerating fatty acyl-CoA and free carnitine.
3. The 4-Step -Oxidation Spiral
Inside the matrix, fatty acyl-CoA is degraded through a repeating sequence of four enzymatic reactions that cleaves two carbons as acetyl-CoA per turn:
The Four-Step Beta-Oxidation Spiral:
R-CH2-CH2-CH2-CO-SCoA (Fatty Acyl-CoA)
|
v [Step 1: Acyl-CoA Dehydrogenase] --> FAD to FADH2 (1.5 ATP)
R-CH2-CH=CH-CO-SCoA (trans-Δ2-Enoyl-CoA)
|
v [Step 2: Enoyl-CoA Hydratase] --> H2O Added
R-CH2-CH(OH)-CH2-CO-SCoA (L-β-Hydroxyacyl-CoA)
|
v [Step 3: β-Hydroxyacyl-CoA DH] --> NAD+ to NADH (2.5 ATP)
R-CH2-CO-CH2-CO-SCoA (β-Ketoacyl-CoA)
|
v [Step 4: β-Ketothiolase] --> CoA-SH added (Cleavage)
R-CH2-CO-SCoA (Shortened by 2C) + CH3-CO-SCoA (Acetyl-CoA to TCA)
- Step 1: Oxidation (Dehydrogenation): Acyl-CoA dehydrogenase introduces a trans double bond between C2 () and C3 (), transferring electrons to enzyme-bound FAD, which passes them to ubiquinone via electron-transferring flavoprotein (ETF). Yields ().
- Step 2: Hydration: Enoyl-CoA hydratase stereospecifically adds water across the trans- double bond, yielding .
- Step 3: Oxidation: oxidizes the -hydroxyl group to a -keto group, reducing to . Yields ().
- Step 4: Thiolytic Cleavage (Thiolysis): uses a free Coenzyme A molecule to cleave the bond between and , releasing acetyl-CoA and a fatty acyl-CoA shortened by two carbons.
Comprehensive Stoichiometric Calculation for Palmitate ()
Palmitic acid () requires 7 cycles of -oxidation and produces 8 molecules of acetyl-CoA:
- From 7 :
- From 7 :
- From 8 (via TCA Cycle):
- Each Acetyl-CoA yields: , , and (Total = per Acetyl-CoA).
- Gross ATP Produced:
- Activation Cost: Spent during conversion to palmitoyl-CoA () =
Notice that older textbooks using obsolete P/O ratios of 3 for NADH and 2 for FADH2 report 129 ATP. Licensure exams require the modern, experimentally validated value of 106 ATP.
Ketone Body Metabolism: Ketogenesis and Ketolysis
During prolonged fasting, starvation, or uncontrolled Type 1 Diabetes Mellitus, carbohydrate availability is severely restricted. Adipose lipolysis floods the liver with free fatty acids, accelerating -oxidation and producing enormous amounts of acetyl-CoA. Concurrently, hepatic oxaloacetate is drained to sustain gluconeogenesis. Because oxaloacetate levels are depleted, excess acetyl-CoA cannot enter the citric acid cycle. The liver shunts this excess acetyl-CoA into ketone bodies:
- Acetoacetate
- D--Hydroxybutyrate (technically a hydroxy acid, but classified metabolically as a ketone body)
- Acetone (metabolically inert volatile byproduct released via the lungs; causes the characteristic "fruity breath" of diabetic ketoacidosis)
Pathway of Hepatic Ketogenesis (Mitochondrial Matrix)
- Thiolase: Two molecules of acetyl-CoA condense: .
- HMG-CoA Synthase (Mitochondrial): Rate-limiting enzyme of ketogenesis; condenses acetoacetyl-CoA with a third acetyl-CoA to form -hydroxy--methylglutaryl-CoA (HMG-CoA).
- HMG-CoA Lyase: Cleaves HMG-CoA to release acetoacetate and acetyl-CoA.
- -Hydroxybutyrate Dehydrogenase: Interconverts acetoacetate and in an -dependent equilibrium. A high matrix ratio (as in active -oxidation) heavily favors -hydroxybutyrate.
Extrahepatic Ketolysis (Ketone Body Utilization)
Ketone bodies are released into the blood and taken up by extrahepatic tissues (cardiac muscle, skeletal muscle, renal cortex, and during starvation, the brain, which adapts to derive of its ATP from ketone bodies):
- is oxidized to acetoacetate by -hydroxybutyrate dehydrogenase, producing .
- Acetoacetate is activated to acetoacetyl-CoA by succinyl-CoA:acetoacetate CoA-transferase (Thiophorase):
- Thiolase cleaves acetoacetyl-CoA with CoA-SH to produce , which enter the TCA cycle.
PRC Licensure High-Yield Principle: Why can't the liver utilize ketone bodies as fuel? The liver completely lacks succinyl-CoA transferase (thiophorase). The liver produces ketone bodies exclusively for export to other tissues; it cannot consume them itself, preventing futile cycles.
A suspension of freshly isolated, intact rat liver mitochondria is supplied with pyruvate, malate, ADP, and inorganic phosphate, demonstrating robust oxygen consumption and ATP synthesis. Adding Compound X completely stops both oxygen consumption and ATP synthesis. Subsequent addition of 2,4-dinitrophenol (DNP) restores rapid oxygen consumption without restoring ATP synthesis. Adding Compound Y instead halts both processes, but adding DNP produces no recovery of oxygen consumption. What are the identities of Compounds X and Y?
Compound X is cyanide (inhibiting Complex IV), and Compound Y is rotenone (inhibiting Complex I)
Compound X is 2,4-dinitrophenol (an uncoupler), and Compound Y is atractyloside (inhibiting ANT)
Compound X is oligomycin (inhibiting the Fo proton channel of ATP synthase), and Compound Y is cyanide (inhibiting Complex IV)
Compound X is antimycin A (inhibiting Complex III), and Compound Y is oligomycin (inhibiting ATP synthase)
Calculate the theoretical net ATP yield obtained from the complete aerobic oxidation of one mole of palmitic acid (C16H32O2) to CO2 and H2O, utilizing standard modern P/O ratios (2.5 for NADH and 1.5 for FADH2) and accounting for the initial activation step.
120 moles of ATP
106 moles of ATP
98 moles of ATP
129 moles of ATP
Which statement correctly describes the biochemical mechanism of carnitine palmitoyltransferase I (CPT-I) and its physiological regulation in hepatocytes?
CPT-I is a cytosolic matrix-facing translocase that requires pyridoxal phosphate to exchange acetyl-CoA for carnitine
CPT-I catalyzes the ATP-dependent cleavage of triacylglycerols in adipose tissue and is inactivated by protein kinase A phosphorylation
CPT-I is an outer mitochondrial membrane enzyme that forms acylcarnitine and is inhibited by malonyl-CoA
CPT-I is an inner mitochondrial membrane enzyme activated by high levels of glucagon and inhibited by citrate
Sections you finish are checked off in the contents.